NVZMY Novozymes A/S Un
$65.02
Novozymes A/S Un (NVZMY) is expected to report earnings on November 19, 2026, before the market open. The consensus earnings estimate is $0.65 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -7.4% since its last earnings release on August 20, 2026.
Novozymes A/S Un Missed Consensus Estimates
Thursday, August 20, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 19
Thursday · Before Open
Earnings Whisper
-
vs $0.65
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$68.67
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Novozymes A/S Un
Novozymes A/S is a biotech company. The Company is engaged in research, development, production and selling enzymes and microorganisms.
Sector
Basic Materials
Industry
Specialty Chemicals
Charts powered in part by Lightweight Charts™ by TradingView.